A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Suspension Injection of Investigational Capsid Inhibitors Compared to Placebo in Healthy Adults

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

June 9, 2026

Study Completion Date

June 9, 2026

Conditions

HIV Infections

Interventions

DRUG

VH4004280

VH4004280 will be administered.

DRUG

Placebo

Placebo will be administered.

DRUG

VH4011499

VH4011499 will be administered.

Trial Locations (2)

GSK Investigational Site, Austin

GSK Investigational Site, Las Vegas